Sendur, M. A. N. Et Al. 2014. Comparison of long-term cardiac effects of 9-and 52-week trastuzumab in HER2-positive early breast cancer.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology , (Illinois, United States Of America).

Sendur, M. A. N., Aksoy, S., Ozdemir, N., Yorgun, H., Yilmaz, F. M., Yazici, O., ... Zungun, C.(2014). Comparison of long-term cardiac effects of 9-and 52-week trastuzumab in HER2-positive early breast cancer. . 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America

Sendur, Mehmet Et Al. "Comparison of long-term cardiac effects of 9-and 52-week trastuzumab in HER2-positive early breast cancer.," 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 2014

Sendur, Mehmet A. Et Al. "Comparison of long-term cardiac effects of 9-and 52-week trastuzumab in HER2-positive early breast cancer.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America, 2014

Sendur, M. A. N. Et Al. (2014) . "Comparison of long-term cardiac effects of 9-and 52-week trastuzumab in HER2-positive early breast cancer.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={Mehmet Ali Nahit Sendur Et Al. }, title={Comparison of long-term cardiac effects of 9-and 52-week trastuzumab in HER2-positive early breast cancer.}, congress name={50th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Illinois}, country={United States Of America}, year={2014}}